z-logo
open-access-imgOpen Access
Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
Author(s) -
Charlotte C. Hamel,
S.F.P.J. Coppus,
Joyce van den Berg,
Esther Hink,
Jacoba van Seeters,
Paul van Kesteren,
Ashley Merién,
B Torrenga,
Rafli van de Laar,
Josien Terwisscha van Scheltinga,
Ingrid P.M. Gaugler-Senden,
Peppino G.C.M. Graziosi,
M Van Rumste,
E. C. M. Nelissen,
Frank P.H.A. Vandenbussche,
Marcus P.M.L. Snijders
Publication year - 2021
Publication title -
eclinicalmedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.915
H-Index - 20
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2020.100716
Subject(s) - medicine , misoprostol , mifepristone , placebo , obstetrics , randomized controlled trial , pregnancy , gestation , adverse effect , medical abortion , gynecology , abortion , surgery , pathology , genetics , alternative medicine , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom